SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: Results from the real world PROPHESYS study

François D'heygere, Christophe George, François Habersetzer, Davender Tripathi, Calvin Q. Pan, Jose A. Giron, Manuela Schmitz, Fernando Tatsch

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)303-304
Number of pages2
JournalAnnals of Hepatology
Volume13
Issue number2
DOIs
StatePublished - 2014
Externally publishedYes

Cite this